Calling patients, caregivers, clinicians, research and private sector workers in BTC to participate

The Precision-BTC Network’s WG5 is charging into the conversation surrounding the role of Artificial Intelligence in the diagnosis and treatment (and care, and surgical intervention…) of biliary tract cancers.

Rather than charge, perhaps casting an inquisitive eye would be a more proper analogy. To better understand stakeholder’s perceptions, concerns and expectations on the topic, Working Group 5 leader Dr Jesper B Andersen and YRI co-Leader Colm O’Rourke have designed a comprehensive survey on the topic.

The survey is divided into seven topics: imaging & endoscopy, pathology, surgery, oncology & early trials, molecular profiling & biomarker development, drug discovery & development, and patient, ethical & legal perspective. Participants are requested to answer only those parts that are relevant to their field of expertise/situation.

Are you a stakeholder willing to share insights on this topic? Help WG5 by answering the survey below.

SURVEY LINK

For more information, contact Dr Andersen or Dr O’Rourke.